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Nitric Oxide Synthesis Inhibition and Anti-Inflammatory Effect 
of Polypeptide Isolated from Chicken Feather Meal 





Nitric oxide (NO) plays a key role in the pathogenesis of inflammation and has been im-
plicated in endotoxin-induced tissue injury. Chicken feather meal is a rich source of amino 
acids that may serve as a peptide hydrolysate to inhibit NO activity. Anti-inflammatory hy-
drolysates of chicken feather meal were prepared and fractionated into five samples based 
on molecular mass. The smallest fraction (<0.65 kDa) exhibited the highest NO inhibitory 
activity without cytotoxicity towards macrophage RAW 264.7 cells. Further subfractions 
were sufficient to obtain amino acid sequences by Q-TOF LC-MS/MS ESI analysis. Of these, 
the SNPSVAGVR (885.97 Da) peptide and its corresponding pure synthetic peptide have 
inhibitory activity against NO production by RAW 264.7 cells (IC50=(55.2±0.2) mM) without 
cytotoxicity. Reverse transcriptase polymerase chain reaction (RT-PCR) and quantitative 
real-time RT-PCR results revealed that the peptide of the obtained fraction reduced tran-
script expression levels of the pro-inflammatory cytokines iNOS, TNF-α, COX-2 and IL-6 in 
lipopolysaccharide-stimulated RAW 264.7 cells. These results suggest that the peptides 
derived from the chicken feather meal protein could potentially be used as a promising 
ingredient in functional foods or nutraceuticals against inflammatory diseases.
Key words: nitric oxide, anti-inflammatory activity, chicken feather meal, protein hydro-
lysate, polypeptide, macrophage RAW 264.7
INTRODUCTION
Inflammation is a host defence mechanism that involves physiological and patholog-
ical processes within an organism, and is induced by the invasion of pathogens or tissue 
injury caused by biological, chemical or physical damage (1). The activation of several 
immune cells (monocytes and macrophages) produces inflammation mediators, such as 
nitric oxide (NO), cyclooxygenase-2 (COX-2), prostaglandins E2 (PGE2) and other pro-in-
flammatory cytokines (iNOS), including tumour necrosis factor alpha (TNF-α), interleukin-6 
(IL-6) and interleukin-1β (2). Macrophages play an important role in inflammation and this 
cellular response is initiated by bacterial lipopolysaccharide (LPS), which is part of the out-
er membrane of Gram-negative bacteria, interferon-γ (IFN-γ) and pro-inflammatory cy-
tokines (3). Oxidative stress is involved in the pathogenesis of several diseases. Physical 
and biochemical processes in the human body generate free radicals as byproducts that 
trigger a wide range of diseases (4). The interaction of reactive nitrogen species and reac-
tive oxygen species (ROS), e.g. NO, with toxic agents is strongly linked with inflammation, 
while the uncontrolled production of these species is linked to several diseases, including 
cancer, coronary heart disease, rheumatoid arthritis, asthma and Alzheimer’s (5). During 
inflammatory processes, inflammatory mediators, such as NO and PGE2, are produced via 
the oxidation of l-arginine by inducible nitric oxide synthase (iNOS) and the conversion of 
arachidonic acid by COX-2. Moreover, NO is a key signalling biological molecule involved 
in vasodilation, regulation of blood pressure, neurotransmission and the host immune 
defence system. Inflammation can be regulated by suppression of the pro-inflammatory 
cytokines and NO production (6).
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Currently, there is an increasing interest in food proteins 
and their constituent peptides as potential candidates for use 
as antioxidant and anti-inflammatory agents (7). The produc-
tion and development of functional food or dietary supple-
ments has increased significantly and these products have 
been used to aid human health (8). Peptides are highly se-
lective, efficient and completely safe for humans (9). These 
peptides are often functionally inactive within native pro-
teins and must be released by hydrolysis using enzymes such 
as Alcalase, Flavourzyme and Neutrase to achieve their spe-
cific bioactive roles (10). Recently, significant pharmaceutical 
research has been undertaken in an effort to use bioactive 
peptides from plants or animals as potential medicines and 
to underpin research into drug development (11). Currently, 
bioactive peptides that display anticancer (12), antimicrobial 
(13), hypocholesterolemic (14), antihypertensive (15), and an-
ti-inflammatory properties (16) have been identified.
Poultry processing plants and related industries are ex-
panding in many countries, especially in Thailand. Although 
chicken feather meal represents around 5–7 % of the body 
mass of chicken, it is a major waste byproduct of poultry pro-
cessing, with large amounts produced annually, and its sub-
stantial accumulation causes potential environmental prob-
lems and pollution. Instead, chicken feather meal can be used 
as an alternative value-added product as animal feed or feed 
supplement and organic fertilizer due to its high (80–90 %) 
protein content, as well as being rich in hydrophobic amino 
acids (17). The objective of this study is to prepare peptides 
from chicken feather meal by enzymatic hydrolysis using mi-
crobial proteases and then to determine the in vitro anti-in-
flammatory effect of the isolated peptide samples on mac-
rophage RAW 264.7 cells. The results indicate that chicken 
feather meal is a suitable source of anti-inflammatory pep-
tides, which can be further developed in the pharmaceuti-




The chicken feather meal used in this study was obtained 
from Betagro Science Center Co., Ltd. (Pathumthani, Thailand) 
and was ground to small particles and dried at 60 °C over-
night. Then it was filtered through a 150-μm sieve to give a 
more homogenous particle size distribution for better accu-
racy and consistency of the results.
Chemicals
Alcalase and Flavourzyme were purchased from Bren-
tag (Mülheim, Germany). Neutrase was purchased from No-
vozymes (Bagsværd, Denmark). Acetic acid, ethanol and 
phosphoric acid were purchased from Merck (Gibbstown, 
NJ, USA). Acetonitrile (ACN), l-α-amino-n-butyric acid, bo-
vine serum albumin (BSA), budesonide, curcumin from 
Curcuma longa (turmeric), Coomassie brilliant blue G-250, 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT), dimethyl sulfoxide (DMSO), disodium hydro-
gen phosphate, Dulbecco’s modified Eagle medium (DMEM), 
foetal bovine serum (FBS), phosphoric acid, formic acid, hy-
drochloric acid, 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid (HEPES), methanol, monosodium dihydrogen 
orthophosphate, mouse interferon gamma (IFN-γ), lipopoly-
saccharides (LPS) from Escherichia coli, potassium persulfate, 
sodium nitrite, (1-naphthyl)ethylenediamine (NED), sodi-
um nitroprusside (SNP), sodium pyruvate, streptomycin sul-
phate, sulphanilamide, and trifluoroacetic acid (TFA) were 
purchased from Sigma-Aldrich, Merck (St. Louis, MO, USA).
Determination of the chicken feather meal  
amino acid content
The amino acid content of the chicken feather meal was 
determined based on the standard AOAC method 994.12 (18). 
One gram of chicken feather meal was dissolved in 5 mL of 6 
M HCl in a test tube and then placed into a heating block at 
110 °C for 24 h to liberate the amino acids. The internal stand-
ard (10 mL 2.5 mM l-α-amino-n-butyric acid in 0.1 M HCl) was 
added to this sample, diluted with deionized water to 250 mL 
and placed in a heating block at 55 °C for 10 min. Amino ac-
ids were analysed by reversed-phase high performance liq-
uid chromatography (RP-HPLC; Waters Corporation, Milford, 
MA, USA) using a Hypersil GOLD column C18 (50 mm×0.5 mm, 
5 µm; Thermo Fisher Scientific, San Jose, CA, USA) shielded by 
a guard column on a Hypersil GOLD (30 mm×0.5 mm, 5 µm 
C18; Thermo Fisher Scientific, San Jose, CA, USA, elution buff-
er of 20 mM sodium acetate (pH=4.90) and 60 % acetonitrile 
(ACN) at a flow rate of 0.3 mL/min.
Preparation of enzymatic hydrolysate from  
chicken feather meal
The sieved chicken feather meal (5 µg) was mixed with 
100 mL of phosphate-buffered saline (PBS; 20 mM phosphate 
buffer, 0.15 M NaCl, pH=7.2) and stirred at 4 °C overnight. The 
suspension was then hydrolysed with one of three types of 
microbial proteases (Alcalase, Flavourzyme (both from Bren-
tag) and Neutrase (Novozymes)) at 0, 1, 2.5 or 5 % (m/V) for 4 h 
at 50 °C and pH=7 (except for Alcalase treatment which was 
at pH=8) with shaking (180 rpm; model Innova 4330 refrig-
erated floor incubator shaker; New Brunswick Scientific (UK) 
Ltd., Hatfield, Herts, UK). After hydrolysis, the mixtures were 
heated to 90 °C for 10 min to inactivate the enzymes and 
the samples were clarified by centrifugation (model Kubo-
ta 6500; Shimadzu, Kyoto, Japan) at 6440×g for 15 min. The 
supernatant (i.e. hydrolysate) was collected and stored at 
–20 °C until use.
Protein content determination
The concentration of the chicken feather meal protein hy-
drolysate was determined according to the Bradford proce-
dure (19), using BSA as the standard protein to construct the 
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calibration curve. For each sample three aliquots (20 μL) were 
separately mixed with 200 μL of the Bradford working solution 
(50 mg of Coomassie brilliant blue G-250 in 50 mL of metha-
nol and 100 mL 85 % (m/V) phosphoric acid) in a 96-well plate 
(flat-bottom 96-well; Bio-Rad Laboratories, Inc., Hercules, MA, 
USA), incubated for 20 min and then the absorbance was meas-
ured at A540 nm with a microplate reader (Multiskan GO; Ther-
mo Fisher Scientific, Waltham, MA, USA). The protein content in 
each sample was determined from the standard curve derived 
from the BSA measurements.
NO radical scavenging assay
The NO radical scavenging assay was slightly modified from 
that previously reported by Chantaranothai et al. (20). The pep-
tide hydrolysates (5 μL) were mixed with 10 mM of SNP in PBS 
and incubated at room temperature for 150 min before the 
addition of 100 μL of Griess reagent (0.33 % sulfanilamide in 
5 % phosphoric acid) and incubation for 5 min. Next, 100 μL 
NED were added and the samples were incubated for 30 min at 
room temperature before measurement of the absorbance at 
540 nm using a microplate reader (model Multiskan GO, Ther-
mo Fisher Scientific Inc., San Jose, CA, USA). The percentage of 
NO inhibition (%) and concentration of hydrolysate that inhibit-
ed 50 % of the NO radical production (IC50) were calculated, the 
latter using the GraphPad Prism v. 6.01 for Windows (GraphPad 
Software Inc., San Diego, CA, USA) (21). Curcumin was used as 
the positive control. The NO scavenging activity (%) was cal-
culated from:
NO inhibition = 
(Acontrol−Ablank)−(Asample−Abackground) ·100 /1/
  (Acontrol−Ablank) 
where Acontrol is the absorbance of the control (no sample), Asample 
is the absorbance of the sample, Abackground is the absorbance of 
the background (colour of the sample), and Ablank is the absorb-
ance of blank (deionized water).
Fractionation and enrichment of the chicken feather  
meal peptide hydrolysate 
Molecular mass cut-off by ultrafiltration
The chicken feather meal peptide hydrolysate was fractionat-
ed through ultrafiltration membranes with molecular mass cut- 
-off (MMCO; Pellicon XL filter; Merck Millipore, Billerica, MA, USA) 
values of 10, 5, 3 and 0.65 kDa to give five different size fractions 
of >10, 5–10, 3–5, 0.65–3 and <0.65 kDa. The obtained protein 
hydrolysate fractions were stored at –20 °C until further use.
Gel filtration chromategraphy 
The fraction with the highest NO radical scavenging ac-
tivity from the ultrafiltration step (i.e.<0.65 kDa fraction) was 
loaded onto a preparative Sephacryl S-100 gel filtration col-
umn (1.6 cm×60 cm, AKTA™ prime with Hitrap™; Amersham 
Biosciences, Uppsala, Sweden). The samples were eluted in 
distilled water at a flow rate of 0.5 mL/min and collected 
in 5-mL fractions (Fraction Collector Frac-950; Amersham 
Biosciences), and the absorbance was monitored at A280 nm to 
determine protein concentration. Fractions in each protein 
peak were pooled and the resulting separate fractions (F1 to 
F4) were assayed for NO radical scavenging activity.
RP-HPLC
The protein fraction obtained by gel filtration chroma-
tography with the highest NO radical scavenging activity (F2) 
was further fractionated by RP-HPLC using a C18 column (250 
mm×4.6 mm, Luna 5U; Phenomenex, Torrance, CA, USA). The 
peptides were eluted at room temperature using a gradient 
(0–100 % mobile phase B for 20 min) of mobile phase A (0.1 %, 
V/V, trifluoroacetic acid; TFA) and B (70 %, V/V, ACN in 0.05 %, 
V/V, TFA) at a flow rate of 0.7 mL/min. Chromatographic anal-
yses were performed using the ChromQuest software (Ther-
mo Fisher Scientific Inc., Waltham, MA, USA) (22). Peptides 
were detected by measuring the absorbance at A280 nm, the 
principal subfractions (F2-1 to F2-5) were isolated and collected, 
and the NO radical scavenging activity of three aliquots was 
determined while the rest was lyophilized.
Identification of anti-inflammatory peptides
The principal subfractions (enriched peptides) obtained 
from the RP-HPLC fractionation that showed a marked NO 
radical scavenging activity and a sufficient yield (F2-1 to F2-3 and 
F2-5) were identified by amino acid sequencing using quadru-
pole time-of-flight (Q-TOF) liquid chromatography-tandem 
mass spectrometry (Q-TOF LC-MS/MS) coupled with elec-
trospray ionization (ESI; model Amazon SL, Bruker, Bremen, 
Germany). The MS/MS data were searched against the Swiss- 
Prot database with the MASCOT package (www.matrixsci-
ence.com) (23). 
Comparison between the NO radical scavenging activity 
of the pure synthetic peptide and enriched enzymatic 
subfraction
The peptide sequences obtained from the Q-TOF LC-MS/
MS ESI analysis were synthesized using a 433A Synergy solid 
phase peptide synthesizer (model ABI 433A; Applied Biosys-
tems, Foster City, CA, USA). The purity of the peptides was ver-
ified by analytical mass spectrometry (model Finnigan™ LXQ™; 
Thermo Fisher Scientific Inc., Waltham) coupled to a Survey-
or HPLC. Ionization was performed in the positive mode. The 
separation was performed at a flow rate of 100 m/min under 
a linear gradient of 5–80 % B for 50 min, where A was 0.1 % 
(V/V) formic acid in water and B was 100 % ACN. Mass spec-
tral data from 300–1500 m/z were collected in positive ioni-
zation mode and HyStar v. 3.2 software (Bruker Daltonics Inc., 
Billerica, MA, USA) (24) was used to interface the HPLC and MS 
systems. All data obtained from LC-MS/MS were analysed us-
ing de novo sequencing. The NO radical scavenging activity of 
the pure synthesized peptides was determined in comparison 
with those obtained from the RP-HPLC fractionation.
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Detection of iNOS, TNF-α, COX-1, COX-2 and IL-6 mRNA by 
two-stage reverse transcriptase (RT)-PCR or quantification by 
two-stage quantitative real time (qrt)-RT-PCR analyses 
Macrophage RAW 264.7 cells were pretreated for 1 h with 
a solvent (negative control), and synthesized peptide at vari-
ous concentrations or 2.5 μg/mL of budesonide (positive con-
trol). The pretreated cells were then stimulated by the addi-
tion of 100 ng/mL of LPS and incubated for 12 h before their 
total RNA was harvested using the MasterPure™ Complete 
DNA and RNA Purification Kit (Epicentre; Lucigen, a part of 
LGC, Biosearch Technologies, Middleton, WI, USA) according 
to the manufacturer’s instruction. The RNA concentration was 
measured using a Nanodrop 2000 UV-Vis spectrophotome-
ter (Thermo Fisher Scientific, Inc.) at 260 nm. Reverse tran-
scription of the total RNA (1 μg) was performed with oligo-dT 
primers using a Precision nanoScript II Reverse Transcription 
Kit (PrimerDesign, Camberley, UK) according to the manufac-
turer’s protocol. The PCR was performed using selective prim-
ers for the β-actin (5’- ACCAACTGGGACGACATGGAGAA-3’ and 
5’-GTGGTGGTGAAGCTGTAGCC-3’), iNOS (5’- CCATCATGGAC-
CACCACACA-3’ and 5’-CCATGCAGACAACCTTGGTG-3’), IL-6 
(5’- CATGTTCTCTGGGAAATCGTGG-3’ and 5’-AACGCACTAG-
GTTTGCCGAGTA-3’), TNF-α (5’-CCTGTAGCCCACGTCGTAGC-3’ 
and 5’-TGACCTCAGCGCTGAGTTG-3’), COX-1 (5’- AGTGCGGTC-
CAACCTTATCC-3’ and 5’- GGTAAAGCCAGGACCCATCTTTC-3’), 
and COX-2 (5’- GGAGAGACTATCAAGATAGT-3’ and 5’- ATGGT-
CAGTAGACTTTTACA-3’).
For the (qrt)-RT-PCR analysis, the PCR mixture comprised 
1 μL cDNA, 1 μL of each primer (10 mM), 7 μL ultrapure wa-
ter and 10 μL 2× qPCRBIO SyGreen Mix (PCR Biosystems Ltd, 
London, UK) to give a final volume of 20 μL. The (qrt)-RT-
PCR reactions (performed separately per gene) were ampli-
fied using a MyGo Pro® Real time PCR apparatus (IT-IS Inter-
national Ltd, Stokesley, UK) and thermal cycles at 95 °C for 2 
min, followed by 40 cycles at 95 °C for 10 s, 68 °C (or 60 °C for 
TNF-α and IL-6) for 20 s and 72 °C for 30 s with melting at 55–
95 °C for 1 min. The RT-PCR was performed using selective 
primers for the β-actin (5’-GATCAAGATCATTGCTCCTCCTG-3’ 
and 5’-CGCAGCTCAGTAACAGTCCG-3’), iNOS (5’-CGGCAAA-
CATGACTTCAGGC-3’ and 5’-TAGGTCGATGCACAACTGGG-3’), 
IL-6 (5’-CTCTCTGCAAGAGACTTCCATCC-3’ and 5’-ACAGGTCT-
GTTGGGAGTGGTATC-3’), TNF-α (5’-GGGCAGGTCTACTTTG-
GAGTCA-3’ and 5’-ACAGACTGGGGGCTCTGAGG-3’), COX-1 
(5’-AGCTGCTGCTGAGAAGGGAGTT-3’ and 5’-GGTAAAGCCAG-
GACCCATCTTTC-3’), and COX-2 (5’-CTGACCCCCAAGGCT-
CAAAT-3’ and 5’-AAGTCCACTCCATGGCCCAG -3’). β-Actin was 
used as the internal reference gene and the three q-PCR re-
actions were analysed by relative quantitation. The relative 
gene expression level was determined using the Ct (threshold 
cycle) value by calculating as follows: 
        Relative gene expression=2–∆∆Ct   /2/
where ∆∆Ct correlates with the increase in the threshold cy-
cle of the gene (25). 
Cell culture
The RAW 264.7 cell line was maintained in complete medi-
um (CM: DMEM supplemented with 10 %, V/V, FBS, 100 U/mL 
penicillin G, 0.4 mg/mL streptomycin sulfate, 1 %, m/V, sodi-
um pyruvate and 1 %, m/V, HEPES) at 37 °C in a humidified 
atmosphere with 5 % (V/V) CO2. For routine maintenance in 
the culture (passage) (22), the cells were seeded in non-tissue 
culture treated dishes at approx. 10 % confluency and grown 
to approx. 80 % confluency, which typically took 2 days. The 
used medium was aspirated, cells were gently rinsed with 
PBS, then dislodged by gently scraping with a rubber spatula 
and harvested by centrifugation (Hettich, Tuttlingen, Germa-
ny) at 15 000×g and 4 °C for 5 min.
Pretreatment of macrophage RAW 264.7 cells
The macrophage RAW 264.7 cells were seeded in 96-well 
plates at N=104 cells/well in 100 μL CM and incubated over-
night at 37 °C in a humidified atmosphere with 5 % CO2. The 
medium was replaced with CM alone (negative control) or 
with different concentrations of the chicken feather meal pro-
tein hydrolysate (or fractions thereafter), or with budesonide 
(2.5 μg/mL) as a positive control, and incubated for 1 h. NO 
production was stimulated by the addition of 100 ng/mL of 
LPS and incubated for 12 h.
Measurement of cell viability/proliferation by the MTT assay
The cytotoxicity activity of the F2 and the peptide from 
F2-1 (SNPSVAGVR) were determined according to Saisavoey et 
al. (22) with slight modifications. The macrophage RAW 264.7 
cells were plated at N=104 cells/well in a 96-well plate and 
then incubated at 37 °C with 5 % (V/V) CO2 for 24 h. Cells were 
then treated with different concentrations of the test sample 
(peptide) and LPS. Subsequently, 100 μL of a 5 mg/mL MTT 
solution (in PBS) were added to each well. Cells were incu-
bated at 37 °C in a humidified atmosphere with 5 % CO2 for 
4 h before the medium was removed and DMSO added at 
100 μL/well to solubilise the formed formazan crystals, and 
subsequently the A540 nm was measured (model Multiskan GO; 
Thermo Fisher Scientific Inc.).
Determination of NO production by macrophage  
RAW 264.7 cells
The level of NO production was determined by measur-
ing nitrite production in the CM according to the Griess reac-
tion. Macrophage RAW 264.7 cells were incubated with the 
test sample at various concentrations (control 0 μg/mL). Then 
50 μL of sulfanilamide were added to 50 μL of the culture su-
pernatant in a 96-well plate and incubated at room tempera-
ture for 10 min before 50 μL of the NED solution were added 
and incubated for 10 min. Finally, the A540 nm was measured 
using a microplate reader (model Multiskan GO; Thermo Fish-
er Scientific Inc.).
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scavenging activity was observed after treatment with 10 mg/
mL Flavourzyme (Table 2). Overall, the hydrolysate obtained 
with 10 mg/mL Flavourzyme exhibited the highest NO radi-
cal scavenging activity, with an IC50=(5.5±1.0) μg/mL. Several 
studies have suggested that the antioxidant activity of pep-
tides in hydrolysates varies depending on their amino acid 
composition, sequence and length (30). This suggests that 
enzymatic hydrolysis with different proteolytic enzymes and 
conditions would lead to the formation of different peptide 
sequences. In the same way, the anti-inflammatory activity 
of the Flavourzyme hydrolysate from M. coruscus showed a 
strong inhibition of NO production in macrophage RAW 264.7 
cells (27). Since the hydrolysate obtained from chicken feather 
meal with 10 mg/mL Flavourzyme had the highest NO radical 
scavenging activity, it was selected for further study.
Statistical analysis
Numerical data are shown as the mean value±standard 
deviation, derived from three independent repeats. The data 
were subjected to analysis of variance followed by Duncan’s 
multiple range post hoc tests, accepting significance at the 
p<0.05 level. The analysis was performed using the SPSS sta-
tistical software (26).
RESULTS AND DISCUSSION
Amino acid composition of chicken feather meal
The chicken feather meal contains essential and non-es-
sential amino acids (Table 1). Glutamic acid, proline, serine, 
glycine and leucine are present in higher mass fractions than 
other amino acids. Active anti-inflammatory peptides from 
Mytilus coruscus were reported to consist of glycine, valine, 
serine, leucine, glutamine and phenylalanine (5,27). Moreover, 
it was reported that peptides consisting of glycine, cysteine, 
alanine, valine and serine could inhibit NO production, while 
peptides comprising glycine, cysteine and histidine exhibited 
anti-inflammatory activity by inhibiting the NF-κB signalling 
pathway (28). Certain amino acids, such as glycine, histidine, 
cysteine, glutamine and tryptophan, have been reported to 
possess anti-inflammatory properties (29).
In vitro NO radical scavenging assay
The anti-inflammatory activity of the crude protein hy-
drolysates of chicken feather meal from the three protease 
digests was tested using a NO radical scavenging assay. NO 
radical scavenging activity of hydrolysates obtained with Al-
calase and Neutrase increased with the increase of enzyme 
concentration up to 25 mg/mL, and then at 50 mg/mL the ac-
tivity decreased. However, a dramatically increased NO radical 





Aspatic acid (Asp) 5.70
Cysteine (Cys) 2.90














Table 2. Effect of enzyme concentration on NO radical scavenging 
activity of chicken feather meal hydrolysates expressed as concentra-
tion of hydrolysate that inhibited 50 % of NO production (IC50)
Enzyme
γ(enzyme)/(µg/mL)
0 10 25 50
IC50/(µg/mL)
Alcalase (134.0±4.7)e (80.6±5.4)d (30.0±1.8)a (40.2±0.8)b
Flavourzyme (158.4±1.5)E (5.5±1.0)A (82.1±7.0)D (68.7±3.6)C
Neutrase (175.7±4.0)ee (133.0±5.4)dd (37.0±0.4)aa (78.7±3.9)cc
Data are shown as mean value±standard deviation of triplicates. 
Different superscripts indicate significant difference (p<0.05). 
Curcumin was used as positive control (IC50=(60.5±3.2) µg/mL)
Enrichment of NO inhibitory peptides from the chicken 
feather meal hydrolysate obtained with 10 µg/mL 
Flavourzyme
The 50 % inhibitory concentrations of the obtained >10, 
5–10, 3–5, 0.65–3 and <0.65 kDa fractions were (21.9±0.7), 
(10.4±0.7), (7.2±0.5), (5.8±0.6) and (3.6±0.3) μg/mL respec-
tively (Table S1). Thus, it can be concluded that the inhibi-
tory activity increased with the decrease of peptide fraction 
size. The molecular mass is an important parameter that cor-
relates with the bioactivity of protein hydrolysates. Previous 
research has shown that the effective hydrolysates depend 
on their molecular mass distribution, e.g. Li et al. (31) reported 
that the peptide fraction with a molecular mass of 200–3000 
Da was probably associated with a higher antioxidant activity, 
Nalinanon et al. (32) reported that low molecular mass pep-
tides contributed to the antioxidant activity, and Wang et al. 
(33) reported that the biological activity of hydrolysates de-
pended on the molecular mass of each peptide. 
Arrays of NO inhibitory peptides with low molecular mass 
fractionated by ultrafiltration were previously shown to be ef-
fective in interacting with internal barriers to promote biologi-
cal activities including antioxidant and anti-inflammatory activ-
ities (34). In addition, Lee et al. (35) also identified low molecular 
mass (<1.3 kDa) anti-inflammatory egg white peptides that 
were able to attenuate the symptoms of inflammatory bowel 
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Fig. 1. Enrichment of bioactive peptides from the <0.65 kDa fraction of chicken feather meal hydrolysate obtained with 10 mg/mL Flavourzyme: 
a) the absorbance values of four fractions obtained after gel filtration chromatography of bioactive peptide, and b) RP-HPLC chromatograph of 
































disease. Anti-inflammatory Leu-Asp-Ala-Val-Asn-Arg (683 Da) 
and Met-Met-Leu-Asp-Phe (655 Da) from Spirulina maxima 
(11), Gln-Cys-Gln-Gln-Ala-Val-Gln-Ser-Ala-Val (1061 Da) from 
Ruditapes philippinarum (5) and Gln-Cys-Gln-Cys-Ala-Val-Glu-
Gly-Gly-Leu (1007 Da) from Crassostrea gigas were also isolat-
ed from marine organisms (36), while the tripeptide Val-Pro-Tyr 
(377 Da) from soybean exhibited anti-inflammatory effects (37). 
Therefore, the <0.65 kDa fraction from chicken feather meal 
was selected for further study. 
Since peptide length is closely related to biological activ-
ities (antioxidant, antihypertensive, antimicrobial and immu-
nomodulatory), gel filtration chromatography is suitable for 
fractionation, enrichment and concentration of proteins and 
peptides (Fig. 1). It has previously been reported to be useful 
for improving the anticancer activities of protein hydrolysates 
(38). Thus, further separation of lyophilized active <0.65 kDa 
fraction yielded four (F1–4) protein fractions based upon segre-
gation of the A280 nm profile (Fig. 1a). Measurement of NO inhib-
itory activity of each of the four fractions revealed that F1 and 
Table 3. Amino acid sequences of RP-HPLC subfractions obtained from the chicken feather meal hydrolysate, identified by Q-TOF LC/MS/MS
Fraction Amino acid sequence M/Da Protein name Organism Accession number
F2-1 SNPSVAGVR 886 Putative E3 ubiquitin-protein ligase SH3RF2 Gallus gallus XP_015157384.1
Putative E3 ubiquitin-protein ligase SH3RF2 ioform X2 Gallus gallus XP_015157384.1
Putative E3 ubiquitin-protein ligase SH3RF2 isoform X1 Gallus gallus XP_414662.3
PRELI domain containing protein 3B Gallus gallus NP_001026037.1
Hypothetical protein RCJMB04_17b4, partial Gallus gallus CAG32065.1
F2-2 SLFLHTHSIVADK 1468 Lactate dehydrogenase Phodilus badius GI629677270
F2-3 AVLKKKVTSTFGR 1435 Cystine/glutamate transporter Gallus gallus XP_426289.3
Dynein heavy chain 1, axonemal Gallus gallus XP_015148334.1
Unconventional myosin-XVI isoform X2 Gallus gallus XP_004938593.1
Unconventional myosin-XVI isoform X1 Gallus gallus XP_416950.3
Transcription initiation factor TFIID subunit 9B Gallus gallus NP_001264725.1
F2-5 LSPWPVKGV 982 Zinc finger matrin-type protein 1-like isoform X1 Gallus gallus XP_004936323.1
Neogenin isoform X6 Gallus gallus XP_015134538.1
Neogenin isoform X5 Gallus gallus XP_015134537.1
Neogenin isoform X4 Gallus gallus XP_015134536.1
Neogenin isoform X3 Gallus gallus XP_015134535.1
F2 had NO inhibitory activity with IC50 values of (73.5±2.8) and 
(34.6±3.4) μg/mL (Table S2), respectively, whereas the yields of 
fractions F3 and F4 were too low to determine their IC50 values. 
Given the higher inhibitory activity (lower IC50 value) of frac-
tion F2, it was selected for further fractionation. The F2 fraction 
was divided into five principal subfractions (F2-1, F2-2, F2-3, F2-4 and 
F2-5) (Fig. 1b) all with NO radical scavenging activity. The yield 
of subfraction F2-4 was too low to determine its IC50 value, while 
the IC50 values of the remaining four fractions were: (16.8±1.5), 
(15.3±0.7), (17.4±0.4) and (34.0±1.9) μg/mL (Table S3), respec-
tively, and they were subjected to amino acid sequencing by 
mass spectrometry.
Identification of peptides by Q-TOF mass spectrometry and 
comparison of the NO radical scavenging activity between 
synthetic and enzymatic peptides
The amino acid sequences and molecular masses of F2-1, 
F2-2, F2-3 and F2-5 are shown in Table 3. The de novo sequencing 
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yielded a homology identification of 100 % based on the Pha-
sianidae family. Each sequence contained 9–13 amino acid 
residues. Fraction F2-1 was identified as Ser-Asn-Pro-Ser-Val- 
-Ala-Gly-Val-Arg (SNPSVAGVR; 886 Da), F2-2 as Ser-Leu-Phe- 
-Leu-His-Thr-His-Ser-Ile-Val-Ala-Asp-Lys (SLFLHTHSIVADK; 
1468 Da), F2-3 as Ala-Val-Leu-Lys-Lys-Lys-Val-Thr-Ser-Thr-Phe- 
-Gly-Arg (AVLKKKVTSTFGR; 1435 Da) and F2-5 as Leu-Ser-Pro- 
-Trp-Pro-Val-Lys-Gly-Val (LSPWPVKGV; 982 Da).
Since F2-1, F2-2, F2-3 and F2-5 exhibited NO radical scaveng-
ing activity, these obtained peptide sequences were synthe-
sized and evaluated for their NO radical scavenging activity. 
However, the SNPSVAGVR peptide showed a high NO radical 
scavenging activity with an IC50 value of (55.2±0.2) mM (Table 
S4). Regarding the relationship between the properties and 
anti-inflammatory activity of the amino acids, all of the pep-
tide sequences contained mainly hydrophobic (leucine, histi-
dine, phenylalanine, proline, tryptophan and valine) and pos-
itively charged (arginine and lysine) amino acids. These have 
been reported previously to have a high antioxidant activity 
(39). Hasegawa et al. (28) reported the anti-inflammatory ac-
tivity of glycine and histidine, suggesting that glycine, histi-
dine and cysteine act as anti-inflammatory agents by reduc-
ing NF-κB activation and inhibiting the expression of IL-6 in 
human coronary arterial endothelial cells. The relationships 
between the structure and the activity of the peptides and 
their mechanism of anti-inflammatory activities are not yet 
fully understood. However, the inhibition of NO production 
(%) by these peptides might be related to their amino acid 
composition and sequences since hydrophobic amino acid 
sequences in peptides have been suggested to play impor-
tant roles in anti-inflammatory activities (40). 
Anti-inflammatory effect of the F2 fraction in LPS-induced 
macrophage RAW 264.7 cells
The F2-1 fraction showed no cytotoxicity to LPS-induced 
RAW 264.7 cells up to the highest tested concentration (120 
µg/mL), where a cell viability of (92.6±0.6) % was still observed 
(Fig. 2a). Thus, the F2-1 fraction can be used at concentrations up 
to 120 μg/mL. Likewise, the bioactive peptides of Lupinus an-
gustifolius were previously shown not to be cytotoxic against 
RAW 264.7 cells (41). Therefore, the nontoxic F2-1 peptide was 
evaluated further by testing its NO inhibitory activity.
In this study, an inflammation-type response was created in 
RAW 264.7 cells by treating them with 100 ng/mL LPS. The NO 
released from the LPS-stimulated RAW 264.7 cells was found 
to decrease with increasing concentrations of F2-1 (2.5-40 μg/
mL), where LPS treatment alone was considered as the control 
(P in Fig. 2b). The enriched F2-1 peptide significantly inhibited 
NO production: at the concentration of 5 μg/mL by <15 % and 
at 20 μg/mL by >85 % (Fig. 2b). Peptides derived from marine 
sources were previously shown to possess NO inhibitory activi-
ties, such as the lupine protein hydrolysate from L. angustifolius 
in LPS-stimulated THP-1 cells (41) and R. philippinarum (5) and 
M. coruscus (27) in LPS-stimulated RAW264.7 cells. Both NO and 
proinflammatory cytokines play a critical role in the physiology 
and pathology of diverse tissues, including the immune sys-
tem of the body. 
Fig. 3 showed that in unstimulated macrophage RAW 264.7 
cells the transcript levels of iNOS, COX-2, TNF-α and IL-6 were 
undetectable, but they were all expressed after treatment with 
LPS, and the F2-1 fraction significantly inhibited these expression 
levels without affecting the constitutive expression of COX-1 
and β-actin transcripts. Cotreatment of the RAW 264.7 cells with 
LPS and F2-1 fraction still revealed the upregulation of COX-2 
and TNF-α, whereas the expression of IL-6 and iNOS transcripts 
was downregulated. On the other hand, cotreatment with F2-1 
fraction negated the LPS-induced expression of COX-2 and 
TNF-α as well as IL-6 and iNOS. It is known that iNOS responds to 
various proinflammatory cytokines, including INF-γ, TNF-α and 
IL-6, and mediates several inflammatory responses (42). More-
over, it has been reported that the inducible isoforms of NOS 
and COX-2 are involved in the production of large amounts of 
NO and PGE2, respectively (43). The activation of NF-κB is re-
sponsible for the induced expression of iNOS and COX-2 (44).
Oxidative stress has been reported to promote inflamma-
tion-related diseases through activation of the NF-κB pathway 
(45). Therefore, an antioxidative effect is a possible mechanism 






































Fig. 2. Effect of different concentrations of F2-1 fraction on: a) viability 
of and b) NO production by lipopolysaccharide (LPS)-stimulated RAW 
264.7 macrophage cells, where N and P represent the negative (cells 
alone) and positive (cells+LPS) controls respectively
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although a detailed mechanism remains unclear. The NO radical 
scavenging assays in both in vitro and cellular models indicated 
that all the chicken feather meal hydrolysate-based fractions, es-
pecially fraction F2–1, can potentially impair oxidative stress. The 
effects of peptide length or peptide mixture were not observed 
in the cellular anti-inflammatory assays, and this could be due 
to complex interactions of the constituents in each hydrolysate 
with the cell matrices, and the likelihood of further proteolytic 
processing of the peptides within the cell cultures.
Several studies have reported anti-inflammatory activities 
of low-molecular-mass peptides derived from food proteins, 
such as soybean (46), milk (47), soybean flour (48), egg (49) and 
whey (50). However, a high-molecular-mass peptide lunasin de-
rived from soybean was reported to down-regulate the produc-
tion of IL-6, IL-1β, NF-κB, iNOS and NO, indicating an anti-in-
flammatory function (46). Moreover, other factors, such as the 
peptide sequence and amino acid composition (not evaluated 
for all the hydrolysates in this study), can also determine the bi-
oactivity of protein hydrolysates. This activity could be due to 
electron donation by the sulfhydryl group of cysteine leading 
to dimerization, although this mechanism would be more rel-
evant in free radical quenching than ROS scavenging. There-
fore, the structure-function relationships of antioxidative and 
anti-inflammatory peptides and protein hydrolysates appear 
complex, especially within physiological matrices.
Anti-inflammatory activity of the synthesized  
SNPSVAGVR peptide
The SNPSVAGVR peptide displayed no cytotoxic ef-
fect against the RAW 264.7 cells at various concentrations 
(15–120 mM), as shown in Fig. 4a. Stimulation of RAW264.7 
cells with LPS (100 ng/mL) resulted in a significant increase 
in NO production compared to the unstimulated group, and 
SNPSVAGVR inhibited this NO production in a dose-depend-
ent manner (Fig. 4b). The potential mechanism underlying 
the anti-inflammatory activity of SNPSVAGVR in LPS-induced 
RAW 264.7 macrophages was evaluated in terms of the tran-
script expression level of proinflammatory mediators. As 
shown in Fig. 5, LPS treatment markedly stimulated the ex-
pression of iNOS, IL-6, TNF-α and COX-2 (but not COX-1) in 
RAW 264.7 cells. When added to the cells, 60 mM of SNPS-
VAGVR blocked the stimulatory effects of LPS on these genes 
(at p<0.05 and p<0.001). It is known that IL-6 and COX-2 have 
important effects on inflammation, and so it is relevant that 
SNPSVAGVR at 60 mM clearly decreased the IL-6 and COX-2 
transcript expression levels by 96 and 83 % respectively. All of 
these results support the conclusion that the synthetic pep-
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Fig. 3. Effect of F2-1 fraction on transcript expression levels of iNOS, 
IL-6, TNF-α, COX-1, COX-2 and β-actin in lipopolysaccharide (LPS)-in-
duced RAW 264.7 macrophage cells. Lane 1=LPS, lane 2=LPS+γ(F2-1 
fraction)=40 µg/mL, lane 3=LPS+budesonide; 2.5 μg/mL (positive 







































Fig. 4. Effect of different concentrations of synthesized SNPSVAGVR 
peptide on: a) viability of and b) NO production by lipopolysaccha-
ride (LPS)-stimulated RAW 264.7 macrophage cells, where N and P 
represent the negative (cells alone) and positive (cells+LPS) controls 
respectively
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Fig. 5. Effects of synthesized SNPSVAGVR peptide on transcript 
expression levels of: a) inducible nitric oxide synthase (iNOS), b) in-
terleukin 6 (IL-6), c) tumour necrosis factor (TNF-α), d) cyclooxygen-
ase-2 (COX-2) and e) cyclooxygenase-1 (COX-1) in lipopolysaccharide 
(LPS)-stimulated RAW264.7 cells measured by qrtRT-PCR. Cells were 
incubated for 12  h with γ(LPS)=100 ng/mL in the presence of c(pep-
tide)=30 (P1), 60 (P2) and 120 (P3) mM, or with γ(budesonide)=2.5 µg/
mL as positive control. Statistical significance is expressed as *p<0.05 
and **p<0.001 compared to LPS
CONCLUSIONS
Our results show that chicken feather meal peptides ob-
tained by microbial enzyme hydrolysis exhibit anti-inflamma-
tory activity, as evaluated by the NO radical scavenging assay. 
The chicken feather meal hydrolysate obtained with 10 mg/
mL Flavourzyme had the highest NO radical scavenging activ-
ity. Peptides with the lowest molecular mass (<0.65 kDa) have 
the highest NO radical scavenging activity. Moreover, the F2-1 
fraction and pure SNPSVAGVR peptide are potent inhibitors 
of the LPS-induced expression of pro-inflammatory cytokines, 
including iNOS, TNF-α, COX-2 and IL-6. These results suggest 
that chicken feather meal hydrolysate can potentially be used 
as a natural anti-inflammatory agent in functional foods or 
pharmaceutical products.
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